trending Market Intelligence /marketintelligence/en/news-insights/trending/ZiY_dp0G3wQ1Lxqmba6khw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Acer Therapeutics raises another $1.6M in stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Acer Therapeutics raises another $1.6M in stock offering

Acer Therapeutics Inc. said it raised additional gross proceeds of about $1.6 million after the underwriters of its common stock offering partially exercised their overallotment option.

Following the underwriters' purchase of an additional 130,000 shares at $12 apiece, the total number of shares sold increased to 1,046,667 shares and the total gross proceeds increased to $12.6 million.

The company plans to use the net proceeds to fund its research and development efforts, to seek regulatory approval for its product Edsivo, to invest in precommercial activities for Edsivo, and for general corporate purposes, including working capital and other general and administrative purposes.

William Blair & Co. LLC acted as sole book-running manager of the offering. H.C. Wainwright & Co. acted as lead manager of the offering.